Induction of Protection against Porcine Cysticercosis by Vaccination with Recombinant Oncosphere Antigens
AUTOR(ES)
Flisser, Ana
FONTE
American Society for Microbiology
RESUMO
Two recombinant Taenia solium oncosphere antigens, designated TSOL18 and TSOL45-1A, were investigated as vaccines to prevent transmission of the zoonotic disease cysticercosis through pigs. Both antigens were effective in inducing very high levels of protection (up to 100%) in three independent vaccine trials in pigs against experimental challenge infection with T. solium eggs, which were undertaken in Mexico and Cameroon. This is the highest level of protection that has been achieved against T. solium infection in pigs by vaccination with a defined antigen. TSOL18 and TSOL45-1A provide the basis for development of a highly effective practical vaccine that could assist in the control and, potentially, the eradication of human neurocysticercosis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=517464Documentos Relacionados
- Protection of Mice against Coccidioides immitis Intranasal Infection by Vaccination with Recombinant Antigen 2/PRA
- Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL.
- Vaccination against Taenia solium cysticercosis
- Protection against feline leukemia by vaccination with a subunit vaccine.
- Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death.
